HAIRY CELL LEUKEMIA VARIANT

Clinical trials for HAIRY CELL LEUKEMIA VARIANT explained in plain language.

Never miss a new study

Get alerted when new HAIRY CELL LEUKEMIA VARIANT trials appear

Sign up with your email to follow new studies for HAIRY CELL LEUKEMIA VARIANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New pill tested to control Tough-to-Treat blood cancer

Disease control Ongoing

This study is testing a daily pill called ibrutinib for people with hairy cell leukemia that has returned after previous treatment. The goal is to see if the drug can control the cancer by blocking a protein that helps the cancer cells grow. Researchers will measure how well pati…

Matched conditions: HAIRY CELL LEUKEMIA VARIANT

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

HAIRY CELL LEUKEMIA VARIANT

Get alerted when new HAIRY CELL LEUKEMIA VARIANT trials appear

New pill tested to control Tough-to-Treat blood cancer